JP2022507795A5 - - Google Patents

Info

Publication number
JP2022507795A5
JP2022507795A5 JP2021527866A JP2021527866A JP2022507795A5 JP 2022507795 A5 JP2022507795 A5 JP 2022507795A5 JP 2021527866 A JP2021527866 A JP 2021527866A JP 2021527866 A JP2021527866 A JP 2021527866A JP 2022507795 A5 JP2022507795 A5 JP 2022507795A5
Authority
JP
Japan
Prior art keywords
optionally substituted
group
alkyl
alkylene
pharmaceutically acceptable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2021527866A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022507795A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2019/062045 external-priority patent/WO2020106636A1/en
Publication of JP2022507795A publication Critical patent/JP2022507795A/ja
Publication of JP2022507795A5 publication Critical patent/JP2022507795A5/ja
Pending legal-status Critical Current

Links

JP2021527866A 2018-11-19 2019-11-18 Ｃ１０環状置換１３員マクロライド及びそれらの使用 Pending JP2022507795A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862769413P 2018-11-19 2018-11-19
US62/769,413 2018-11-19
PCT/US2019/062045 WO2020106636A1 (en) 2018-11-19 2019-11-18 C11-cyclic substituted 13-membered macrolides and uses thereof

Publications (2)

Publication Number Publication Date
JP2022507795A JP2022507795A (ja) 2022-01-18
JP2022507795A5 true JP2022507795A5 (https=) 2022-11-29

Family

ID=68965978

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021527866A Pending JP2022507795A (ja) 2018-11-19 2019-11-18 Ｃ１０環状置換１３員マクロライド及びそれらの使用

Country Status (12)

Country Link
US (1) US20220177508A1 (https=)
EP (1) EP3883945A1 (https=)
JP (1) JP2022507795A (https=)
KR (1) KR20210123288A (https=)
CN (1) CN113646319A (https=)
AU (2) AU2019385383B2 (https=)
BR (1) BR112021009607A2 (https=)
CA (1) CA3120235A1 (https=)
IL (2) IL310280A (https=)
MX (1) MX2021005421A (https=)
SG (1) SG11202105228SA (https=)
WO (1) WO2020106636A1 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW202313065A (zh) * 2021-05-28 2023-04-01 美商季卡尼醫療公司 用於治療遺傳疾病之化合物
WO2023235380A1 (en) * 2022-06-01 2023-12-07 Zikani Therapeutics, Inc. Macrolides for treating genetic diseases
WO2023250513A1 (en) * 2022-06-24 2023-12-28 Zikani Therapeutics, Inc. 13-membered macrolide compounds for treating diseases mediated by abnormal protein translation
KR20250048331A (ko) * 2022-08-11 2025-04-08 지카니 테라퓨틱스, 인크. 치료용 아자케톨라이드 제조용 합성 공정 및 중간체

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA70972C2 (uk) * 1998-11-20 2004-11-15 Пфайзер Продактс Інк. 13-членні азаліди і їх застосування як антибіотиків
BRPI0017013B1 (pt) * 2000-01-27 2015-07-14 Zoetis P Llc Composição de antibiótico azalídeo e método para sua obtenção
WO2003014136A1 (en) * 2001-08-08 2003-02-20 Taisho Pharmaceutical Co., Ltd. 11a-AZALIDE COMPOUNDS AND PROCESS FOR PRODUCING THE SAME
WO2004108744A2 (en) * 2003-05-19 2004-12-16 Prasad K Deshpande Azalides and azaketolides having antimicrobial activity
US8097708B2 (en) * 2006-02-07 2012-01-17 Taisho Pharmaceutical Co., Ltd. 10a-Azalide compound
US20130102551A1 (en) * 2010-07-01 2013-04-25 Andreas Hotte Antibiotic compositions
JP6437523B2 (ja) * 2013-04-04 2018-12-12 プレジデント アンド フェローズ オブ ハーバード カレッジ マクロライドならびにそれらの調製および使用の方法
CN106998685A (zh) * 2014-10-08 2017-08-01 哈佛大学的校长及成员们 14‑元酮内酯及其制备和使用方法
EP3273969A4 (en) * 2015-03-25 2018-11-21 President and Fellows of Harvard College Macrolides with modified desosamine sugars and uses thereof

Similar Documents

Publication Publication Date Title
JP2022507795A5 (https=)
DK2997011T3 (en) SULFAMOYLPYRROLAMIDE DERIVATIVES AND USE THEREOF AS MEDICINES TO TREAT HEPATITIS B
JP2021534124A5 (https=)
DK3024819T3 (en) GLYOXAMIDE-SUBSTITUTED PYRROLAMIDE DERIVATIVES AND THE USE THEREOF AS MEDICINES FOR TREATING HEPATITIS B
TW201828948A (zh) 用於抑制精胺酸酶活性的組合物及方法
JP2006511583A5 (https=)
JP2017537158A5 (https=)
EA200300424A1 (ru) Соли изотиазол-4-карбоксамида и их применение в качестве антигиперпролиферативных агентов
JP2017537949A5 (https=)
JP2020507589A5 (https=)
JP2011506566A5 (https=)
JP2013544276A5 (https=)
EA200970535A1 (ru) Антибактериальные производные хинолина
KR102519536B1 (ko) 트리시클릭 회전장애이성질체 화합물
RU2007101653A (ru) Производные 1-азабицикло[3.3.1]нонанов
EA200970534A1 (ru) Антибактериальные производные хинолина
RU2007130144A (ru) Гетероциклические соединения в качестве антагонистов cccr2b
JP2013515037A5 (https=)
AR064318A1 (es) Compuesto y composicion derivada de aril sulfamida, uso del compuesto y proceso para la preparacion del compuesto
JP2004525183A5 (https=)
CA2463544A1 (en) Cross-linked glycopeptide-cephalosporin antibiotics
JP2022507776A5 (https=)
MX384745B (es) Proceso para la preparación de compuestos de 5-amino-6h-tiazolo[4,5-d]pirimidina-2,7-diona 3-sustituidos.
JP2017535566A5 (https=)
JP2016501844A5 (https=)